Retrospective Continuous Glucose Monitor (CGM) Study on Glycemic Response and Body Composition in College Students
RCSOGRABCICS
A Retrospective Study of Individual Glycemic Response Based on CGM Wearable Devices in Weight and Body Composition Management Among College Students
1 other identifier
observational
59
1 country
1
Brief Summary
This retrospective study evaluates the real-world effect of individualized glycemic response-guided dietary management, based on continuous glucose monitoring (CGM), on weight and body composition in overweight and obese university students. All data for this analysis were retrospectively retrieved from the archived records of a randomized controlled trial conducted at He University, in which 60 students (body mass index \[BMI\] ≥ 24 kg/m² or elevated body fat percentage) had worn CGM sensors for 4 weeks. The archived records show that the exposed group (n = 30) had received individualized dietary guidance generated from their own glucose responses, including structured CGM reports, meal composition and eating-order advice, and standardized feedback, whereas the non-exposed group (n = 30) had worn CGM without receiving any dietary guidance. One non-exposed participant was excluded from this retrospective analysis for missing primary outcome data, leaving 59 participants for analysis. The archived dataset contains body composition (weight, body mass index \[BMI\], body fat mass, percent body fat, skeletal muscle mass, visceral fat level) and eating behavior records at Day 0, Day 28, and Day 90. This analysis examines whether the 4-week intervention produced sustained, fat-mass-driven improvements in body composition and whether changes in eating behavior mediated these effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2026
CompletedFirst Submitted
Initial submission to the registry
August 25, 2026
CompletedFirst Posted
Study publicly available on registry
September 14, 2026
CompletedSeptember 14, 2026
August 1, 2026
1 month
August 25, 2026
September 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Time above range (TAR)
Change in the percentage of time above the target glucose range recorded in the archived CGM dataset. Unit of Measure: Percent of time (%).
Data recorded at baseline, Day 14, and Day 28
Body weight
Change in body weight recorded in the archived InBody 120 dataset. Unit of Measure: Kilogram (kg).
Data recorded at Day 0, Day 28, and Day 90
Secondary Outcomes (31)
Body fat mass
Data recorded at Day 0, Day 28, and Day 90
Body mass index (BMI)
Data recorded at Day 0, Day 28, and Day 90
Percent body fat
Data recorded at Day 0, Day 28, and Day 90
Skeletal muscle mass
Data recorded at Day 0, Day 28, and Day 90
Visceral fat level
Data recorded at Day 0, Day 28, and Day 90
- +26 more secondary outcomes
Study Arms (2)
Exposed (n=30)
Participants whose archived records from the parent trial indicate that they had received a 4-week individualized glycemic response-guided dietary intervention based on continuous glucose monitoring (CGM) data: dietary behavior observation during weeks 1-2, followed by structured CGM reports, dietary guidance on meal composition and eating order, and standardized researcher feedback during weeks 3-4.
Non-exposed (n=29)
Participants whose archived records from the parent trial indicate that they had worn the CGM system for 4 weeks without receiving dietary guidance or feedback. CGM data were visible during weeks 1-2 and blinded during weeks 3-4. Participants maintained their usual diet and lifestyle. One of the 30 non-exposed participants enrolled in the parent trial was excluded from this retrospective analysis for missing primary outcome data.
Eligibility Criteria
Overweight and obese university students (aged 18-25 years) at He University, Shenyang, Liaoning, China, whose records are contained in the archived dataset of a randomized controlled trial of a 4-week continuous glucose monitoring (CGM)-guided personalized dietary intervention. Participants had a body mass index (BMI) ≥ 24 kg/m² or elevated body fat percentage (≥ 25% in men, ≥ 32% in women) and self-reported at least two unhealthy eating behaviors. Of the 60 participants enrolled in the parent trial (30 per group), 59 were included in this retrospective analysis (30 exposed, 29 non-exposed); one non-exposed participant was excluded for missing primary outcome data. All participants were free of diabetes, prediabetes, and other exclusion conditions defined in the study protocol.
You may qualify if:
- University students aged 18 to 25 years
- Body mass index (BMI) ≥ 24.0 kg/m², or body fat percentage ≥ 25% (male) / ≥ 32% (female)
- Self-reported presence of at least two unhealthy eating behaviors
- Written informed consent
You may not qualify if:
- Polycystic ovary syndrome (PCOS)
- Weight gain or glycemic abnormality induced by medications (e.g., glucocorticoids, antipsychotics, insulin secretagogues)
- Diagnosed diabetes (type 1 or type 2) or prediabetes (fasting glucose ≥ 6.1 mmol/L or glycated hemoglobin (HbA1c)≥ 5.7%)
- Diagnosed dyslipidemia with lipid-lowering medication
- High risk of eating disorders identified by the Eating Disorder Diagnostic Scale (EDDS)
- Severe psychiatric disorders or psychotropic medication use
- Pregnancy, lactation, or planned pregnancy within 6 months
- Allergy to CGM adhesive or hydrogel, or active skin disease affecting sensor wear
- Professional athletes (high-intensity physical activity ≥ 5 times/week, ≥ 60 min/session)
- Weight change \> 5% of initial body weight within the past 3 months
- Participation in other commercial or clinical weight-loss programs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- He Eye Hospitallead
Study Sites (1)
He University, Shenyang, Liaoning, China
Shenyang, Liaoning, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jun Li, MD
He University, Shenyang, Liaoning, China
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 25, 2026
First Posted
September 14, 2026
Study Start
June 27, 2026
Primary Completion
July 30, 2026
Study Completion
August 15, 2026
Last Updated
September 14, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share